Where to buy TB-500 (Thymosin Beta-4 fragment) in the UK: the sellers with a verifiable COA
The newest verifiable TB-500 certificate on any UK seller's website is on Lab77Peptides (lab77peptides.uk), analysed 23 Oct 2026 (task #244121 on Janoshik's site); 12 verified sellers hold one covering TB-500, listed newest first below.
Who holds the newest TB-500 report (12 verified UK sellers)
| Seller | Newest TB-500 report | Age of that report | |
|---|---|---|---|
| Lab77Peptides lab77peptides.uk | 23 Oct 2026 | 30 days | verify |
| Camo Chem camochem.uk | 11 Sep 2026 | 2 months, 11 days | verify |
| Imperialpeptides imperialpeptides.co.uk | 6 Aug 2026 | 3 months, 16 days | verify |
| Biohacklondon biohacklondon.com | 19 Jun 2026 | 5 months, 3 days | verify |
| Kingston Peptides kingstonpeptides.com | 4 Jun 2026 | 5 months, 18 days | verify |
| Phoenixbiolabs phoenixbiolabs.net | 13 May 2026 | 6 months, 9 days | verify |
| Peptifyuk peptifyuk.com | 11 May 2026 | 6 months, 11 days | verify |
| MyoTech myotech.co | 5 May 2026 | 6 months, 17 days | verify |
| Ascendpeptidesuk ascendpeptidesuk.com | 27 Mar 2026 | 7 months, 26 days | verify |
| Xlpeptides xlpeptides.com | 23 Mar 2026 | 7 months, 30 days | verify |
| Clinicore clinicore.co.uk | 19 Jan 2026 | 10 months, 3 days | verify |
| Tested Peptides testedpeptides.co.uk | 8 Jan 2026 | 10 months, 14 days | verify |
Newest report first. Every report was opened on Janoshik's own website and names the seller as the client. The date is the analysis date printed on the report. The verify link opens the laboratory, never the shop. Audit findings, not recommendations.
A record of paperwork, not a recommendation: The Peptide Watch sells nothing, takes no money from sellers and links to none of them.
Why the date matters · What purity means · What TB-500 is · Regulators · Every report
Every TB-500 purity report we have read (15), one row per report
The 15 verifiable TB-500 certificates we have read, newest first
Each row was opened on Janoshik's own site by a real page load and transcribed. The client column is the name the laboratory printed; a certificate counts as a seller's own only when that name is the seller. The report date is the analysis date printed on the report where we have read it, otherwise the date the laboratory received the sample. The verify link opens the laboratory, never the shop. Audit findings, not recommendations.
| Seller | Task | Client on the report | Report date | Result | Batch | |
|---|---|---|---|---|---|---|
| Lab77Peptides | #244121 | Lab77peptides.uk | 23 Oct 2026 | TB-500 (TB-4) · 10.07 mg · 98.602% | L77TB27 | verify |
| Camo Chem | #229223 | Camo Chem UK | 11 Sep 2026 | TB-500 · 5.27 mg · 96.593% | TB500-500EU-09-26 | verify |
| Imperialpeptides | #214255 | Imperial Peptides UK | www.imperialpeptides.co.uk | 6 Aug 2026 | TB-500 · 5.48 mg · 98.750% | TB5-07/28 | verify |
| Lab77Peptides | #208428 | Lab77peptides.co.uk | 6 Aug 2026 | TB-500 · 10.96 mg · 99.020% | L77TB268 | verify |
| Biohacklondon | #168545 | BioHack London Ltd | 19 Jun 2026 | TB-500 · 10.56 mg · 99.102% | 2026-06 | verify |
| Kingston Peptides | #162965 | Kingston Peptides | 4 Jun 2026 | TB-500 · 10.27 mg · 99.945% | TBF-101A | verify |
| Phoenixbiolabs | #147248 | www.phoenixbiolabs.net | 13 May 2026 | TB-500 · 9.61 mg · 99.811% | Batch-0100 used in vials + pen(s) | verify |
| Peptifyuk | #149061 | Peptify UK | 11 May 2026 | TB-500 · 5.22 mg · 98.700% | 2026/04 | verify |
| MyoTech | #150965 | Myotech | 5 May 2026 | TB-500 (TB4) · 5.33 mg · 99.370% | TB5-545AY | verify |
| Ascendpeptidesuk | #125456 | Ascend Peptides UK | 27 Mar 2026 | TB-500 · 12.09 mg · 99.944% | 20260114 | verify |
| Xlpeptides | #124102 | XL Peptides | 23 Mar 2026 | TB-500 · 4.90 mg · 99.007% | 269TB5 | verify |
| Imperialpeptides | #105941 | Imperial Peptides UK | www.imperialpeptides.co.uk | 5 Feb 2026 | TB-500 · 5.47 mg · 99.094% | TB5-12/27 | verify |
| Clinicore | #100583 | clinicore | 19 Jan 2026 | TB-500 · 11.61 mg · 99.331% | tb10101 | verify |
| Tested Peptides | #97473 | [email protected] | 8 Jan 2026 | TB-500 (TB4) · 4.86 mg · 99.393% | Unknown | verify |
| Xlpeptides | #56757 | XL Peptides | 28 Jan 2025 | TB-500 · 4.91 mg · 99.572% | 007001 | verify |
Why the date on a certificate matters
What a purity figure means
The purity on a Janoshik report is the share of the main peak in an HPLC chromatogram. 99.5% means that 99.5% of what the detector saw was one substance and 0.5% was something else. It is not the amount in the vial: that is the separate quantity line, in milligrams. It does not by itself prove which substance the peak is: that is identity, confirmed by mass spectrometry. And it says nothing about sterility, endotoxins or heavy metals, which are separate tests.
A purity figure printed on a shop page with no report behind it is a claim, not a measurement. Between two reports, the difference that matters is rarely 99.2% against 99.8%; it is whether the report exists at all, names the seller as the client, covers this compound on its own, and is recent.
What TB-500 is, and what it is sold as
TB-500 is a synthetic fragment of the naturally occurring protein Thymosin Beta-4, studied in research on cell migration and angiogenesis. Because it is usually sold alongside BPC-157, it inherits exactly the same certificate problems.
| Development status | Phase 3 complete, no approval. RGN-259, thymosin beta-4 eye drops, completed phase 3 for neurotrophic keratopathy with orphan designation but had no FDA approval as of April 2026. Of the 18 registered thymosin beta-4 trials, 6 are ReGenTree's and 5 are Beijing Northland Biotech's. None studies TB-500. |
|---|---|
| Originator | Thymosin beta-4 is a natural human protein; TB-500 is a synthetic fragment of it with no named originator. Rights: RegeneRx Biopharmaceuticals holds the thymosin beta-4 patents; its joint venture ReGenTree develops RGN-259, thymosin beta-4 eye drops. Nobody holds rights to, or develops, the TB-500 fragment. |
| Registered clinical trials | 18 on ClinicalTrials.gov |
Most of the evidence is about a different molecule. Thymosin beta-4 is a 43-amino-acid protein your own cells make, and it has a large literature: 937 PubMed papers and 3 clinical trials, including a placebo-controlled intravenous safety study in healthy volunteers and a venous-ulcer trial, both from 2010. TB-500 is a short synthetic fragment of it. Only 31 papers name TB-500 at all, and most of those are reviews or doping-detection methods, not studies of the fragment itself.
The fragment's own evidence is thin and recent. The clearest study of TB-500 as sold is a 2026 rat Achilles-tendon experiment that combined it with BPC-157. There is no human trial of TB-500, so any claim that the full protein's results transfer to the fragment is an assumption, not a finding.
It is a banned substance in sport. WADA's 2026 Prohibited List names "Thymosin-β4 and its derivatives e.g. TB-500" under S2.3, growth factors and growth factor modulators, a class prohibited at all times, in and out of competition. Buyers who are tested athletes should know that before they read any certificate.
The published record in numbers, and the sources
| Papers on PubMed | 937 |
|---|---|
| Indexed as rat or mouse studies | 353 |
| Indexed as clinical trials | 6 |
| Published since 2020 | 195 |
Counts are from PubMed on 15 September 2026 using the queries recorded in our evidence file. A description of the published record, not medical advice and not an argument for or against use.
- A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin beta4 in healthy volunteers (Ann N Y Acad Sci, 2010, PMID 20536472)
- The effect of thymosin treatment of venous ulcers (Ann N Y Acad Sci, 2010, PMID 20536470)
- Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study (Jt Dis Relat Surg, 2026, PMID 42542926)
- Rapid and harmonized analytical workflow for the determination of peptidic and non-peptidic doping agents (Analyst, 2026, PMID 42328738)
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance (Sports Med, 2026, PMID 41966639)
- RegeneRx Biopharmaceuticals
- RegeneRx regulatory update on RGN-259 (PR Newswire)
- Eyes On Eyecare, April 2023, phase 3 neurotrophic keratitis trial
What regulators say about TB-500
In the UK. Not a licensed medicine in the UK. Prohibited in sport at all times under WADA S2.3.
WADA, The 2026 Prohibited List (International Standard), valid 1 January 2026, section S2.3 Growth factors and growth factor modulators, page 8. S2.3 lists "Thymosin-β4 and its derivatives e.g. TB-500" among growth factors prohibited at all times, in and out of competition. Source.
What the 15 TB-500 certificates show
We have read 15 Janoshik reports covering TB-500, published by 12 UK sellers. Each was opened on Janoshik's own website. All 15 name the seller itself as the client. 6 of the 15 are dated within the last six months and 1 is more than a year old. The newest is dated 23 Oct 2026 and the oldest 28 Jan 2025.
All 15 reports give a purity figure for TB-500. The figures run from 96.593% to 99.945%, and 11 of the 15 are at 99% or above. A purity figure describes the sample the laboratory received, not every vial from that batch.
Read directly from the newest reports: Lab77Peptides: task #244121, analysed 23 Oct 2026, 10.07 mg recovered at 98.602%, client Lab77peptides.uk; Camo Chem: task #229223, analysed 11 Sep 2026, 5.27 mg recovered at 96.593%, client Camo Chem UK; Imperialpeptides: task #214255, analysed 6 Aug 2026, 5.48 mg recovered at 98.750%, client Imperial Peptides UK.
A certificate is a batch document. The lines that matter are the compound (it must say TB-500, not only a batch code), the client (the shop, not its supplier) and the analysis date. A new batch is untested until a new report appears.
TB-500 in the UK at a glance
| Active UK sellers listing TB-500 | 138 |
|---|---|
| Of which publish a verifiable own-name certificate | 18 |
| Of which name no laboratory at all | 26 |
Counted from the vendor ledger at build time. The A-Z directory lists every seller and what each publishes instead.
Questions people ask
Which UK sellers publish a verifiable Janoshik certificate naming TB-500?
As of 22 November 2026, 12: Lab77Peptides, Camo Chem, Imperialpeptides, Biohacklondon, Kingston Peptides, Phoenixbiolabs, Peptifyuk, MyoTech, Ascendpeptidesuk, Xlpeptides, Clinicore, Tested Peptides. Each has a report on Janoshik's own website that names the seller as the client and lists TB-500. That is a statement about paperwork, not a recommendation; The Peptide Watch does not recommend anywhere to buy TB-500.
How recent is the newest TB-500 certificate from a UK seller?
The newest we have read is Janoshik task #244121, analysed 23 Oct 2026. It is published by Lab77Peptides and names it as the client. A certificate covers one batch, so an old one says little about stock on sale today.
How do I check that a certificate for TB-500 is genuine?
Four things: an independent laboratory is named; the client field names the seller you are buying from, not a supplier; the compound line says TB-500; and the report's task number and key open the same report on the laboratory's own website (verify.janoshik.com). A branded PDF with no laboratory name and no verification code fails on the first check, however professional it looks. The free COA Checker on this site runs the checks for you.
Is TB-500 a licensed medicine in the UK?
Not a licensed medicine in the UK. Prohibited in sport at all times under WADA S2.3. RGN-259, thymosin beta-4 eye drops, completed phase 3 for neurotrophic keratopathy with orphan designation but had no FDA approval as of April 2026. Of the 18 registered thymosin beta-4 trials, 6 are ReGenTree's and 5 are Beijing Northland Biotech's. None studies TB-500. The Peptide Watch does not give legal or medical advice.
Why does The Peptide Watch not say where to buy TB-500?
Because the site records paperwork, not recommendations. A verifiable certificate proves that a sample of one batch was tested. It does not prove the vial you receive matches it, and it says nothing about whether anyone should use TB-500. Listing which sellers publish a certificate you can check, and which publish nothing, is as far as the evidence goes.
The Peptide Watch's position on TB-500
Not a licensed medicine in the UK. Prohibited in sport at all times under WADA S2.3. The Peptide Watch reads the certificates UK sellers publish and does not recommend anywhere to buy TB-500. Sellers on this page are listed by the date of their newest TB-500 certificate and by nothing else. If you can verify a seller's testing, you can at least judge its evidence; if you cannot, you are taking the seller's word for what is in the vial. See how UK testing compares across every seller in the market statistics.
An honest note: a verifiable certificate proves a sample of a batch was tested, not that the specific vial you receive matches it, see what this can and can't tell you. The Peptide Watch sells no TB-500 and links to no shop; this is research-use-only information, not medical or dosing advice.
All peptides · Other compounds: BPC-157 · GHK-Cu · Ipamorelin · CJC-1295 · MOTS-c · Epithalon · Selank · Semax · Tesamorelin · Melanotan 2 · KPV · PT-141 · SS-31 · DSIP · NAD+ · Melanotan 1 · AOD-9604 · 5-Amino-1MQ · Glutathione · Kisspeptin · Thymosin Alpha-1 · GHRP-6 · HGH Fragment 176-191 · IGF-1 LR3 · FOXO4-DRI · Oxytocin · SLU-PP-332 · MK-677 · GLOW and KLOW blends · Sermorelin · GHRP-2 · Hexarelin · ARA-290 · AHK-Cu